Bharat Book

Central Nervous System Partnering Terms and Agreements

Press Release   •   Dec 16, 2013 09:38 IST

Dec 16, 2013 : Bharat Book Bureau presents the new report, on 'Central Nervous System Partnering Terms and Agreements'  also provides a detailed understanding and analysis of how and why companies enter central nervous system partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors central nervous system technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 1,500 links to online copies of actual central nervous system deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

The initial chapters of this report provide an orientation of central nervous system dealmaking and business activities. Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in central nervous system dealmaking since 2007 covering trends by year, deal type, stage of development, technology type and therapeutic indication. In addition the chapter includes an analysis of financial deal terms by stage at signing covering headline value, upfront payment, milestone payments and royalty rates. Analysis includes median values and distribution of values for each stage of development.

Chapter 3 provides a review of the leading central nervous system deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of central nervous system deals, as well as contract documents available in the public domain. Where available, each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

Chapter 5 provides comprehensive access to all central nervous system deals since 2007 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand.

Table of contents:

Executive Summary
Chapter 1 – Introduction

Chapter 2 – Trends in central nervous system dealmaking
2.1. Introduction
2.2. Central nervous system partnering over the years
2.3. Bigpharma central nervous system dealmaking activity
2.4. Bigpharma not active in Central nervous system
2.5. Central nervous system partnering by deal type
2.6. Central nervous system partnering by industry sector
2.7. Central nervous system partnering by stage of development
2.8. Central nervous system partnering by technology type
2.9. Central nervous system partnering by CNS indication
2.10. Average deal terms for central nervous system
2.10.1 Central nervous system headline values
2.10.2 Central nervous system upfront payments
2.10.3 Central nervous system milestone payments
2.10.4 Central nervous system royalty rates

Chapter 3 – Leading central nervous system deals
3.1. Introduction
3.2. Top central nervous system deals by value
3.3. Top central nervous system deals involving bigpharma

Chapter 4 – Bigpharma central nervous system deals
4.1. Introduction
4.2. How to use bigpharma partnering deals
4.3. Bigpharma central nervous system partnering company profiles
Aspen Pharmacare
Baxter International
Bayer Healthcare
Bayer Schering Pharma
Biogen Idec
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Dainippon Sumitomo
Dainippon Pharmaceutical
Eli Lilly
Endo Pharmaceuticals
Forest Laboratories
Forest Laboratories Ireland
Johnson & Johnson
Kyowa Hakko Kirin
Merck & Co
Merck KGaA

For more information kindly visit :

Related link :

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Follow us on twitter: 
Follow us on linked in : 
Our Blog : 

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.